AtriCure
ATRC
147 hedge funds and large institutions have $1.05B invested in AtriCure in 2018 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 62 increasing their positions, 32 reducing their positions, and 14 closing their positions.
2,651% more call options, than puts
Call options by funds: $7.57M | Put options by funds: $275K
157% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 14
94% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 32
17% more funds holding
Funds holding: 126 → 147 (+21)
0.41% more ownership
Funds ownership: 89.04% → 89.45% (+0.41%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
4% less capital invested
Capital invested by funds: $1.1B → $1.05B (-$48.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.8M |
| 2 |
O
OppenheimerFunds
New York
|
+$11.4M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
+$10.2M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$10.2M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HEC
Hudson Executive Capital
New York
|
-$32.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.11M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$2.39M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.63M |
ATRC Hedge Fund Activity: Q4 2018 in Review
147 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2018, worth a combined $1.05B — down 4.4% from $1.1B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ATRC positions and 14 closed out — a net gain of 22 holders — while 62 added to existing stakes and 32 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $14.8M. The largest seller was Hudson Executive Capital, cutting an estimated $32.5M.
- 147 institutional investors held AtriCure (ATRC) as of Q4 2018, up from 126 in Q3 2018.
- Funds reported $1.05B of AtriCure stock for Q4 2018, down 4.4% quarter-over-quarter.
- 36 funds opened new AtriCure positions in Q4 2018 and 14 closed out, a net change of +22 holders.
- The largest AtriCure buyer in Q4 2018 was Fidelity Investments, an estimated $14.8M added.
- The largest AtriCure seller in Q4 2018 was Hudson Executive Capital, an estimated $32.5M sold.
Based on aggregated 13F filings for Q4 2018.